cesarean delivery (CD), intrauterine fetal demise, and multiple gestations were excluded from the study. Early ROM was defined as ROM at a modified Bishop score <5, cervical dilation <4cm, or cervical effacement <80%. The rate of clinical chorioamnionitis was compared between women with early and late ROM. Maternal demographics and neonatal outcomes were collected. Fisher's exact test, Shapiro Wilk normality test and Mann Whitney U were performed. RESULTS: 279 women were included, of which 24 developed clinical chorioamnionitis (8.6%). Women who developed clinical chorioamnionitis were younger, of lower parity, lower weight, delivered at later gestational ages, and had a lower Bishop score, more cervical examinations and a longer time from ROM to delivery. They also had a higher CD rate. Among all women, ROM at an effacement of <80% was associated with a significantly higher rate of clinical chorioamnionitis (15.4% vs 6.0%, p¼0.017). This difference was not found in multiparous women. The rate of CD was also significantly higher for all patients with early ROM by any of the definitions (32% vs 17.5%, p¼0.031). CONCLUSION: Our data suggests that early ROM at a cervical effacement of <80% is associated with an increased rate of clinical chorioamnionitis in patients undergoing induction of labor. When stratifying for parity, this association was present in nulliparous women only. There was also a significant increase in the rate of CD in patients with early ROM. Our findings should be considered when determining the optimal time for artificial ROM during induction of labor.
OBJECTIVE: CDC and WHO guidelines state that pregnant women and their partners should not travel to >70 Zika virus (ZIKV) affected countries, and couples trying to conceive should delay 2-6 months after any travel (Table 1) . These recommendations carry the implicit assumption that ZIKV risk is high in every area where ZIKV has ever been observed, and remains high in places that experienced epidemics in 2015-2017. The goal of our study was to quantify the risk of infection and birth defects for travelers based on updated estimates of transmissibility under epidemic and endemic conditions. STUDY DESIGN: We reviewed the literature to find critical values for estimating the risk from ZIKV under endemic conditions (assuming long term circulation and high levels of population immunity), and epidemic conditions (recent introduction with low levels of population immunity). We used the assumptions outlined in Table 2 to calculate the weekly risk of infection and birth defects in female travelers and female partners of male travelers. RESULTS: We found that the weekly risk of infection for a pregnant female traveler in an area with epidemic conditions is 13 per 1,000 and the risk of birth defects 13 per 10,000 (Table 2) . However, for travelers to endemic areas the risk of ZIKV-associated birth defects are much lower: < 1 per 10,000 for pregnant female travelers and for pregnant partners of male travelers, even under the conservative assumption of a 50% per act transmission probability. CONCLUSION: While there is a non-zero risk of contracting ZIKV, the overall risk is low, especially in the >40 countries with endemic transmission currently included in the travel ban. Guidelines recommending complete cessation of travel may be overly restrictive. Quantification of risk can facilitate shared decision making regarding travel during pregnancy.
Poster Session III OBJECTIVE: Existing data regarding the association of chorioamnionitis and child neurodevelopmental outcomes are limited by a focus on early preterm populations and short duration of follow-up. Our objective was to assess long -term child neurodevelopmental outcomes after exposure to chorioamnionitis during the late preterm and term periods. STUDY DESIGN: This is a secondary analysis of a multicenter randomized controlled trial of treatment for subclinical hypothyroidism or hypothyroxinemia during pregnancy. Trained research personnel abstracted all records and performed child evaluations. All women delivering singleton live births at or after 34 weeks' gestation and whose neonates had at least 3 years of neurodevelopmental data were included. Chorioamnionitis was diagnosed clinically based on attending confirmation of maternal fever (!37.8 C) and no other defined infection. The primary outcome was intelligence quotient (IQ) score at 5 years of age (Wechsler Preschool and Primary Scale of Intelligence-III). Secondary outcomes included the Bayley Scales of Infant Development (12 and 24 months), the Differential Ability Scales-II for IQ (36 months), the Conners' Rating Scales for child attention (48 months), and the Child Behavioral Checklist for behavioral and social competency (36 and 60 months). Offspring whose mothers had chorioamnionitis were compared to those whose mothers did not using univariable and multivariable analyses. RESULTS: A total of 1203 women were enrolled in the trial, and 1117 (93%) mother-child pairs were included in this secondary analysis. The majority (93.2%) delivered after 37 weeks (mean GA 38.9 AE 1.5 weeks). The 5.1% (N¼57) of women with chorioamnionitis were younger and more likely to deliver post-term, and be of Hispanic ethnicity, primiparous, and delivered by cesarean. The mean (S.D.) IQ for 5 year old children who were exposed to chorioamnionitis did not differ from those not exposed (95 AE 13 vs. 95 AE 15, p¼0.88), a finding which remained non-significant after multivariable adjustment for potential confounders (b 1.6, 95% CI -1.9 to 5.0). Similarly, no secondary outcomes differed at any age based on fetal exposure to chorioamnionitis. CONCLUSION: Among children who delivered in the late preterm or term period, a clinical diagnosis of chorioamnionitis was not associated with adverse neurodevelopmental outcomes in early childhood.
